YC W20

Ochre Bio

RNA medicines for liver diseases

About

Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.

Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Ochre Bio.

HealthcareTherapeuticsBiotechGenomics